White Papers

  1. Pharma R&D Annual Review Supplement: New Active Substances 4/15/2026

    Last year was by some distance the best year ever in terms of new active substances. Explore the 105 new debuts that easily outstrips that of the previous record holder, 2021’s, 97.

  2. Futureproofing Post-Approval Compliance 4/15/2026

    In the post-approval stage, a synergistic operating model brings PV and regulatory functions under one umbrella: a single governance structure with shared decision cycles, templates, and evidence.

  3. What Re-Acquisition In Retinal Imaging Is Really Costing Your Program 4/6/2026

    High screen failure rates and patient dropout often stem from preventable imaging errors. Learn how proactive quality control and patient-centric logistics secure critical retinal trial data.

  4. A New Era Of ADC Development Demands A New Kind Of Partner 3/30/2026

    Explore how to navigate the evolution of antibody-drug conjugates by mastering AI-driven selection, dose optimization, and new regulatory strategies for earlier-line clinical success.

  5. Innovating With Generative And Agentic Artificial Intelligence 3/30/2026

    Discover how specialized AI is revolutionizing clinical trials by enhancing data quality and operational speed through curated training, human oversight, and objective scientific analysis.

  6. Combination Therapy Dose Optimization In Oncology Trials 3/30/2026

    Optimize dose selection in oncology trials by moving beyond toxicity limits. Use advanced modeling and benefit-risk analysis to improve efficacy and meet modern regulatory standards.

  7. The Patient Experience Paradox: eCOA Strategy Overhaul 3/25/2026

    European regulatory shifts now require the systematic integration of patient data. Success depends on aligning clinical and market access strategies through rigorous evidence generation.

  8. Implications Of Assessing Overall Survival In Oncology Studies 3/25/2026

    New oncology standards mandate pre-specified survival analysis to catch long-term harm. Learn how to implement hazard ratio thresholds and the ICH E9(R1) framework for global compliance.

  9. The Silent Saboteurs: Why Rater Drift And Site Unpreparedness Cost CNS Trials More 3/25/2026

    High-end technology cannot fix poor rater preparation or complex patient needs. True data integrity requires bridging the gap between digital platforms and the reality of clinical implementation.

  10. 10 Clinical Research Practices That Feel Like Compliance (But Aren't) 3/24/2026

    Many clinical research routines are driven by habit, not regulation. This guide clears up 10 common misconceptions to streamline workflows and reduce unnecessary admin work.